[Perspectives of the preventive treatment of patients after myocardial infarction].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control; D003645:Death, Sudden / Q000517:prevention & control; D005081:Exercise Therapy; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001241:Aspirin; D013442:Sulfinpyrazone
Perspektywy profilaktycznego leczenia chorych po zawale serca.